New CONMED (CNMD) director Celine Christine Martin reports no common stock holdings

Rhea-AI Filing Summary

CONMED Corp director Celine Christine Martin has filed an initial Form 3 reporting her holdings in the company’s common stock. The filing notes that she became a Director of CONMED on July 1, 2026 and currently reports no directly owned shares of CONMED common stock. Form 3 serves as the starting point for tracking any future changes in her ownership.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Martin Celine Christine

Role null

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 0 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares owned following Form 3: 0 shares Director appointment date: July 1, 2026

2 metrics

Shares owned following Form 3 0 shares Directly owned CONMED common stock reported on initial Form 3

Director appointment date July 1, 2026 Footnote states Celine Christine Martin became a Director on this date

Key Terms

Form 3, beneficial ownership, Director

3 terms

Form 3 regulatory

"Celine Christine Martin has filed an initial Form 3 reporting her holdings"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"Form 3 serves as the starting point for tracking any future changes in her ownership"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Director financial

"Celine Christine Martin became a Director of CONMED on July 1, 2026"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 07/02/2026 - 05:06 PM Accepted by SEC EDGAR 07/02/2026 - 05:06 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Martin Celine Christine

(Last) (First) (Middle)

C/O CONMED CORPORATION

11311 CONCEPT BOULEVARD

(Street)

LARGO FLORIDA 33773

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/01/2026

3. Issuer Name and Ticker or Trading Symbol
CONMED Corp [ CNMD ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	0	D(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Celine Christine Martin became a Director of CONMED on July 1, 2026.

	/s/ Thomas Fistek for Celine Christine Martin by Power of Attorney	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the CONMED (CNMD) Form 3 for Celine Christine Martin show?

The Form 3 shows that director Celine Christine Martin reports no directly owned shares of CONMED common stock. This filing establishes her initial ownership position for future insider transaction reporting and regulatory transparency purposes.

When did Celine Christine Martin become a director of CONMED (CNMD)?

Celine Christine Martin became a Director of CONMED on July 1, 2026. This date is disclosed in a footnote and explains why the Form 3 initial beneficial ownership statement is being filed at this time.

Does the CONMED (CNMD) Form 3 report any insider buying or selling?

The Form 3 does not report any insider buying or selling. It is an initial beneficial ownership statement indicating that director Celine Christine Martin currently reports zero directly owned shares of CONMED common stock.

Why is a Form 3 filing important for CONMED (CNMD) investors?

Form 3 is important because it establishes a baseline of an insider’s holdings when they become a reporting person. For CONMED, it shows director Celine Christine Martin’s starting position, enabling future comparison with any later Form 4 or Form 5 filings.

What type of security is covered in this CONMED (CNMD) Form 3?

The Form 3 covers CONMED’s common stock as the relevant security. It indicates that, following the reported date, director Celine Christine Martin holds zero directly owned shares of this common stock class.